Ophthalmology Advances Span Drugs, AI, Infusions
Dermatologists advise people taking GLP-1 medications to pay attention to changes in skin quality and consider avoiding harsh retinols, as treatment and weight loss may affect collagen, skin laxity and the skin barrier. They recommend discussing skin changes and an appropriate routine with a dermatologist, while emphasizing that potential skin effects should not deter eligible patients from the medications’ health benefits. Eye-care professionals should also monitor patients taking GLP-1 drugs: rapid improvements in blood sugar can temporarily worsen diabetic retinopathy in people with previously poor glucose control, while evidence about a direct effect of the medications on the condition remains unsettled.
How it spread
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?






